Volumetric Measurement for Comparison of the Accuracy between Intraoperative CT and Postoperative MR Imaging in Pituitary Adenoma Surgery

References

1. 1.↵
   1. Jane JA Jr.,
   2. Laws ER Jr.

   . The surgical management of pituitary adenomas in a series of 3,093 patients. J Am Coll Surg 2001;193:651–59

   PubMedWeb of Science
2. 2.↵
   1. Wilkins RH,
   2. Rengachary SS

   1. Hardy J

   . Trans-sphenoidal approach to the pituitary gland. In: Wilkins RH, Rengachary SS. eds. Neurosurgery. New York: McGraw-Hill; 1996:1375–84
3. 3.↵
   1. Cushing H.

   . Surgical experiences with pituitary disorders. JAMA 1914;63:1515–25
4. 4.↵
   1. Cappabianca P,
   2. Cavallo LM,
   3. Colao A,
   4. et al

   . Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 2002;97:293–98

   PubMedWeb of Science
5. 5.↵
   1. Agha A,
   2. Sherlock M,
   3. Brennan S,
   4. et al

   . Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005;90:6355–60

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Asthagiri AR,
   2. Laws ER Jr.,
   3. Jane JA Jr.

   . Image guidance in pituitary surgery. Front Horm Res 2006;34:46–63

   CrossRefPubMed
7. 7.↵
   1. Doppman JL,
   2. Zvi R,
   3. Shawker TH,
   4. et al

   . Intraoperative US of the pituitary gland: work in progress. Radiology 1994;192:111–15

   PubMedWeb of Science
8. 8.↵
   1. Ram Z,
   2. Shawker T,
   3. Bradford M,
   4. et al

   . Intraoperative ultrasound-directed resection of pituitary tumors. Neurosurgery 1995;79:225–30
9. 9.↵
   1. Uhl E,
   2. Zausinger S,
   3. Morhard D,
   4. et al

   . Intraoperative computed tomography with integrated navigation system in a multidisciplinary operating suite. Neurosurgery 2009;64:231–39

   CrossRefPubMed
10. 10.↵
    1. Rumboldt Z,
    2. Huda W,
    3. All JW.

    . Review of portable CT with assessment of a dedicated head CT scanner. AJNR Am J Neuroradiol 2009;30:1630–36

    Abstract/FREE Full Text
11. 11.↵
    1. Mettler FA Jr..,
    2. Thomadsen BR,
    3. Bhargavan M,
    4. et al

    . Medical radiation exposure in the U.S. in 2006: preliminary results. Health Phys 2008;95:502–07

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Abosch A,
    2. Tyrrell JB,
    3. Lamborn KR,
    4. et al

    . Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411–18

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Barahona MJ,
    2. Sojo L,
    3. Wagner AM,
    4. et al

    . Determinants of neurosurgical outcome in pituitary tumors. J Endocrinol Invest 2005;28:787–94

    PubMed
14. 14.↵
    1. Chen JC,
    2. Amar AP,
    3. Choi S,
    4. et al

    . Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 2003;98:967–73

    PubMedWeb of Science
15. 15.↵
    1. Chuang CC,
    2. Chang CN,
    3. Wei KC,
    4. et al

    . Surgical treatment for severe visual compromised patients after pituitary apoplexy. J Neurooncol 2006;80:39–47

    CrossRefPubMed
16. 16.↵
    1. Bourdelot A,
    2. Coste J,
    3. Hazebroucq V,
    4. et al

    . Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly. Eur J Endocrinol 2004;150:763–71

    Abstract
17. 17.↵
    1. De Tommasi C,
    2. Vance ML,
    3. Okonkwo DO,
    4. et al

    . Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J Neurosurg 2005;103:825–30

    PubMedWeb of Science
18. 18.↵
    1. Esposito V,
    2. Santoro A,
    3. Minniti G,
    4. et al

    . Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients. Neurol Sci 2004;25:251–56

    CrossRefPubMed
19. 19.↵
    1. Kreutzer J,
    2. Vance ML,
    3. Lopes MB,
    4. et al

    . Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 2001;86:4072–77

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Kristof RA,
    2. Schramm J,
    3. Redel L,
    4. et al

    . Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas. Acta Neurochir (Wien) 2002;144:555–61

    CrossRefPubMed
21. 21.↵
    1. Fahlbusch R,
    2. Ganslandt O,
    3. Buchfelder M,
    4. et al

    . Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg 2001;95:381–90

    PubMedWeb of Science
22. 22.↵
    1. Jones J,
    2. Ruge J.

    . Intraoperative magnetic resonance imaging in pituitary macroadenoma surgery: an assessment of visual outcome. Neurosurg Focus 2007;23:E12

    PubMed
23. 23.↵
    1. Ntoukas V,
    2. Krishnan R,
    3. Seifert V.

    . The new generation Polestar N20 for conventional neurosurgical operating rooms: a preliminary report. Neurosurgery 2008;62:82–89

    CrossRefPubMed
24. 24.↵
    1. Hall WA,
    2. Kowalik K,
    3. Liu H,
    4. et al

    . Costs and benefits of intraoperative MR-guided brain tumor resection. Acta Neurochir Suppl 2003;85:137–42

    PubMedWeb of Science
25. 25.↵
    1. Levivier M,
    2. Wikler D,
    3. De Witte O,
    4. et al

    . PoleStar N-10 low-field compact intraoperative magnetic resonance imaging system with mobile radiofrequency shielding. Neurosurgery 2003;53:1001–07

    PubMedWeb of Science
26. 26.↵
    1. Nimsky C,
    2. Ganslandt O,
    3. Fahlbusch R.

    . Comparing 0.2 Tesla with 1.5 Tesla intraoperative magnetic resonance imaging analysis of setup, workflow, and efficiency. Acad Radiol 2005;12:1065–79

    CrossRefPubMed
27. 27.↵
    1. Gerlach R,
    2. du Mesnil de Rochemont R,
    3. Gasser T,
    4. et al

    . Feasibility of Polestar N20, an ultra-low-field intraoperative magnetic resonance imaging system in resection control of pituitary macroadenoma: lessons learned from the first 40 cases. Neurosurgery 2008;63:272–84

    CrossRefPubMed
28. 28.↵
    1. Prokop M

    . Multislice CT. Technical principles and future trends. Eur Radiol 2003;13 (suppl 5):M3–M13

    CrossRefPubMed
29. 29.↵
    1. Nomikos P,
    2. Ladar C,
    3. Fahlbusch R,
    4. et al

    . Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir (Wien) 2004;146:27–35

    CrossRefPubMed
30. 30.↵
    1. Zhang X,
    2. Fei Z,
    3. Zhang J,
    4. et al

    . Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol 1999;52:380–85

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Alameda C,
    2. Lucas T,
    3. Pineda E,
    4. et al

    . Experience in management of 51 non-functioning pituitary adenomas: indications for post-operative radiotherapy. J Endocrinol Invest 2005;28:18–22

    PubMedWeb of Science
32. 32.↵
    1. Colao A,
    2. Cerbone G,
    3. Cappabianca P,
    4. et al

    . Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 1998;21:284–90

    PubMedWeb of Science
33. 33.↵
    1. Dekkers OM,
    2. Pereira AM,
    3. Roelfsema F,
    4. et al

    . Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006;91:1796–801

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Greenman Y,
    2. Ouaknine G,
    3. Veshchev I,
    4. et al

    . Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumor quiescence and regrowth. Clin Endocrinol (Oxf) 2003;58:763–69

    CrossRefPubMed
35. 35.↵
    1. Marazuela M,
    2. Astigarraga B,
    3. Vicente A,
    4. et al

    . Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 1994;17:703–07

    PubMedWeb of Science
36. 36.↵
    1. Soto-Ares G,
    2. Cortet-Rudelli C,
    3. Assaker R,
    4. et al

    . MRI protocol technique in the optimal therapeutic strategy of non-functioning pituitary adenomas. Eur J Endocrinol 2002;146:179–86

    Abstract
37. 37.↵
    1. Woollons AC,
    2. Hunn MK,
    3. Rajapakse YR,
    4. et al

    . Non-functioning pituitary adenomas: indications for postoperative radiotherapy. Clin Endocrinol (Oxf) 2000;53:713–17

    CrossRefPubMed